2015-08-05 – Page 2 – China Stock Advice

CBPO [China Biologic Products] 8-K: (Original Filing)

[August 5, 2015 100 F Street, N.E. Ladies and Gentlemen: We were previously independent registered public accounting firm for China Biologic Products, Inc. (“the Company”) and, under the date of March 4, 2015, we reported on the consolidated financial statements of the Company as of and for the years ended December 31, 2014 and 2013, and the effectiveness of internal] [FOR RELEASE August 5, 2015 China Biologic Reports Financial Results for the Second Quarter of 2015 2Q15 Total Sales Increased 31.6% YoY to $79.1 Million 2Q15 Non-GAAP Net Income Increased 39.5% YoY to $28.6 Million 1H15 Total Sales Increased 28.5% YoY to $149.4 Million 1H15 Non-GAAP Net Income Increased 35.1% YoY to $53.5 Million BEIJING, China – August 5, 2015] []

By info| 2016-03-25T03:58:42+00:00 August 5th, 2015|Categories: CBPO, Chinese Stocks, SEC Original|Tags: 0001369868, 2015-08-05, 2836, 8-K, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

CBPO [China Biologic Products] 8-K: August 5, 2015 100 F Street, N.E. Ladies

[August 5, 2015 100 F Street, N.E. Ladies and Gentlemen: We were previously independent registered public accounting firm for China Biologic Products, Inc. (“the Company”) and, under the date of March 4, 2015, we reported on the consolidated financial statements of the Company as of and for the years ended December 31, 2014 and 2013, and the effectiveness of internal] [FOR RELEASE August 5, 2015 China Biologic Reports Financial Results for the Second Quarter of 2015 2Q15 Total Sales Increased 31.6% YoY to $79.1 Million 2Q15 Non-GAAP Net Income Increased 39.5% YoY to $28.6 Million 1H15 Total Sales Increased 28.5% YoY to $149.4 Million 1H15 Non-GAAP Net Income Increased 35.1% YoY to $53.5 Million BEIJING, China – August 5, 2015] []

By info| 2016-03-25T04:00:46+00:00 August 5th, 2015|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: 0001369868, 2015-08-05, 2836, 8-K, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

CBPO [China Biologic Products] IRANNOTICE: (Original Filing)

[China Biologic Products, Inc. 8th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China August 5, 2015 VIA EDGAR 100 F Street, N.E. Re: Notice of Disclosure Filed in Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the]

By info| 2016-03-25T04:01:45+00:00 August 5th, 2015|Categories: CBPO, Chinese Stocks, SEC Original|Tags: 0001369868, 2015-08-05, 2836, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO, IRANNOTICE|0 Comments

CBPO [China Biologic Products] IRANNOTICE: China Biologic Products, Inc. 8th Floor, Jialong International

[China Biologic Products, Inc. 8th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China August 5, 2015 VIA EDGAR 100 F Street, N.E. Re: Notice of Disclosure Filed in Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the]

By info| 2016-03-25T04:02:58+00:00 August 5th, 2015|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: 0001369868, 2015-08-05, 2836, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO, IRANNOTICE|0 Comments

CBPO [China Biologic Products] 10-Q: (Original Filing)

[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang Chief Financial Officer (Principal Financial Officer)]

By info| 2016-03-25T04:04:29+00:00 August 5th, 2015|Categories: CBPO, Chinese Stocks, SEC Original|Tags: 0001369868, 10-Q, 2015-08-05, 2836, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

CBPO [China Biologic Products] 10-Q:

[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang Chief Financial Officer (Principal Financial Officer)]

By info| 2016-03-25T04:05:48+00:00 August 5th, 2015|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: 0001369868, 10-Q, 2015-08-05, 2836, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

LITB [LightInTheBox] SC 13D/A: (Original Filing)

[JOINT FILING AGREEMENT AOGANG International (Hong Kong) Corporation Limited Zhentao Wang Director ZheJiang AoKang Shoes Co., Ltd. Zhentao Wang Chairman of the Board AoKang Investment Holdings Co., Ltd. Zhentao Wang Chairman of the Board Mr. Zhentao Wang Mr. Jinquan Wang EX-99.1 2 d31577dex991.htm EX-99.1] [JOINDER AGREEMENT King & Wood Mallesons 13/F, Gloucester Tower, The Landmark 15 Queens Road Central Central Hong Kong T F www.kwm.com Details Buyer Name AOGANG International (Hong Kong) Corporation Limited Incorporated in Hong Kong Address Rm. 19C, Lockhart Ctr., 301-307 Lockhart Rd., Wan Chai, Hong Kong Fax +86 577 6728 8833 Email aks@aokang.com Attention Director Recitals A Company Ceyuan Investors] [Incorporated in China with limited liability HONG KONG BRANCH HONG KONG BRANCH Private and Confidential AOGANG International (Hong Kong) Corporation Limited Our RefNo. CP-150487 Attn: Mr. WANG Zhentao, Director 15 July 2015 Dear Sirs, FACILITY LETTER Agricultural Bank of China Limited Hong Kong Branch (the Bank) is pleased to inform you that it will consider requests made by the Borrower(s)] [ABC (2012) 3009-2 Agreements Regarding the Issue of Foreign Related Letter of Guarantee/Standby Letter of Credit No.: 33050120150000106 Dear customer, ZheJiang AoKang Shoes Co., Ltd. Applicant (full name): Agricultural Bank of China Limited, Yongjia Branch Guarantor (full name): The Applicant makes an application to the Guarantor, asking the latter to issue an foreign related letter of guarantee/standby letter of credit.] [CUSIP No. 53225G102 13D Page 2 of 15 Pages 1 NAME OF REPORTING PERSON AOGANG INTERNATIONAL (HONG KONG) CORPORATION LIMITED I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* ¨ x (a) 3 SEC USE ONLY 4 SOURCE OF FUNDS* AF , BK 5 ¨ N/A]

By info| 2016-03-27T22:49:42+00:00 August 5th, 2015|Categories: Chinese Stocks, LITB, SEC Original|Tags: 0001523836, 2015-08-05, 5961, LITB, RETAIL-CATALOG and MAIL-ORDER HOUSES, SC_13D.A|0 Comments

LITB [LightInTheBox] SC 13D/A: JOINT FILING AGREEMENT AOGANG International (Hong Kong) Corporation

[JOINT FILING AGREEMENT AOGANG International (Hong Kong) Corporation Limited Zhentao Wang Director ZheJiang AoKang Shoes Co., Ltd. Zhentao Wang Chairman of the Board AoKang Investment Holdings Co., Ltd. Zhentao Wang Chairman of the Board Mr. Zhentao Wang Mr. Jinquan Wang EX-99.1 2 d31577dex991.htm EX-99.1] [JOINDER AGREEMENT King & Wood Mallesons 13/F, Gloucester Tower, The Landmark 15 Queens Road Central Central Hong Kong T F www.kwm.com Details Buyer Name AOGANG International (Hong Kong) Corporation Limited Incorporated in Hong Kong Address Rm. 19C, Lockhart Ctr., 301-307 Lockhart Rd., Wan Chai, Hong Kong Fax +86 577 6728 8833 Email aks@aokang.com Attention Director Recitals A Company Ceyuan Investors] [Incorporated in China with limited liability HONG KONG BRANCH HONG KONG BRANCH Private and Confidential AOGANG International (Hong Kong) Corporation Limited Our RefNo. CP-150487 Attn: Mr. WANG Zhentao, Director 15 July 2015 Dear Sirs, FACILITY LETTER Agricultural Bank of China Limited Hong Kong Branch (the Bank) is pleased to inform you that it will consider requests made by the Borrower(s)] [ABC (2012) 3009-2 Agreements Regarding the Issue of Foreign Related Letter of Guarantee/Standby Letter of Credit No.: 33050120150000106 Dear customer, ZheJiang AoKang Shoes Co., Ltd. Applicant (full name): Agricultural Bank of China Limited, Yongjia Branch Guarantor (full name): The Applicant makes an application to the Guarantor, asking the latter to issue an foreign related letter of guarantee/standby letter of credit.] [CUSIP No. 53225G102 13D Page 2 of 15 Pages 1 NAME OF REPORTING PERSON AOGANG INTERNATIONAL (HONG KONG) CORPORATION LIMITED I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* ¨ x (a) 3 SEC USE ONLY 4 SOURCE OF FUNDS* AF , BK 5 ¨ N/A]

By info| 2016-03-27T22:50:50+00:00 August 5th, 2015|Categories: Chinese Stocks, LITB, Webplus ver|Tags: 0001523836, 2015-08-05, 5961, LITB, RETAIL-CATALOG and MAIL-ORDER HOUSES, SC_13D.A|0 Comments

XUE [Xueda Education] SC 13D: (Original Filing)

[Dated: August 5, 2015 XIAMEN INSIGHT INVESTMENT CO., LTD. SHENZHEN YELINWAN INVESTMENT PLANNING CO., LTD. ZHANG Hao Chairman LIAO Chunrong Director NEW INSIGHT HOLDINGS GROUP CO., LTD. LIAO Chunrong LIAO Chunrong Director] [SCHEDULE 13D CUSIP No. 98418W109 Page 2 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Xiamen Insight Investment Co., Ltd. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ¨ ¨ (a) 3 SEC USE ONLY 4 SOURCE OF FUNDS OO]

By info| 2016-03-13T05:39:12+00:00 August 5th, 2015|Categories: Chinese Stocks, SEC Original, XUE|Tags: 0001499619, 2015-08-05, 8200, SC_13D, SERVICES-EDUCATIONAL SERVICES, XUE|0 Comments

DQ [DAQO NEW ENERGY] 6-K: (Original Filing)

[Daqo New Energy Announces Phase 3A Polysilicon Manufacturing Expansion Project to Increase Production Capacity to 18,000 Metric Tons CHONGQING, China — August 4, 2015 — Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy" or the "Company"), a leading manufacturer of high-purity polysilicon for the solar PV industry, today announced that the Company's board of directors has approved its Phase] []

By info| 2016-03-28T05:54:42+00:00 August 5th, 2015|Categories: Chinese Stocks, DQ, SEC Original|Tags: 0001477641, 2015-08-05, 3674, 6-K, DQ, SEMICONDUCTORS and RELATED DEVICES|0 Comments